The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation
NCT03190772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94
Last updated 2018-11-07
Summary
The study aimes at identifying whether positive expectations have an impact on the way depressive participants experience emotions in the form of sadness.
Conditions
- Major Depressive Episode
Interventions
- OTHER
-
Placebo nasal spray
The placebo nasal spray consists of sesame oil and does not contain any active drug.
- OTHER
-
Film sequence
All groups watch the film sequence that is supposed to induce sadness.
Sponsors & Collaborators
-
Philipps University Marburg
lead OTHER
Principal Investigators
-
Winfried Rief, Professor · Philipps University Marburg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
Countries
- Germany
Study Locations
More Related Trials
-
Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder
NCT01650740 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression
NCT05849272 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Duloxetine on Interoceptive Awareness
NCT00337012 ·Status: UNKNOWN
-
A Study of the Neurobiology of Depression
NCT01051466 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
NCT03559192 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Seasonal Affective Disorder
NCT00046449 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MD-120 in Patients With Depression
NCT04345471 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849901 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder
NCT03374475 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
NCT01000805 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
NCT05792540 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT01447576 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
NCT00191919 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
NCT00048204 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)
NCT00839176 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-61393215 in the Treatment of Depression
NCT04080752 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
NCT00413023 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
NCT00191061 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder
NCT07253207 ·Status: COMPLETED ·Phase: PHASE3
-
Modafinil for Atypical Depression
NCT00215176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
NCT00057226 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562 ·Status: COMPLETED ·Phase: PHASE3
-
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
NCT00479726 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
NCT01808612 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
NCT06958692 ·Status: RECRUITING ·Phase: PHASE3